Sign in

CIK 0001579428

  • Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
454241907
Phone
+1 212-332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,086,500
in 1 filing, $2.1M under 10b5-1 plans

Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jacobson Mark L. −$2.1M Chief Operating Officer sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2026-04-22 Maizel Ari Chief Commercial Officer Exercise or conversion 10b5-1 +7,500 $70.73 $530K 7,500
2026-04-22 Maizel Ari Chief Commercial Officer Sale 10b5-1 −7,500 $182.42 $1.4M 0
2026-04-22 Maizel Ari Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −7,500 23,710
2026-04-21 Maizel Ari Chief Commercial Officer Grant or award · Performance Stock Units +7,224 7,224
2026-02-26 Maizel Ari Chief Commercial Officer Grant or award · Restricted Stock Units +16,385 16,385
2026-01-21 Maizel Ari Chief Commercial Officer Exercise or conversion 10b5-1 +7,500 $70.73 $530K 7,500
2026-01-21 Maizel Ari Chief Commercial Officer Sale 10b5-1 −7,500 $184.44 $1.4M 0
2026-01-21 Maizel Ari Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −7,500 31,210
2025-02-24 Maizel Ari Chief Commercial Officer Grant or award · Performance Stock Units +7,740 7,740
2025-02-21 Maizel Ari Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +7,816 7,816
2025-02-21 Maizel Ari Chief Commercial Officer Grant or award · Restricted Stock Units +7,740 7,740

Page 1 of 1 · 11 trades